$PL

Robinson Kristen sold $930K of PL (indirect holdings)

Robinson Kristen sold 37,107 indirectly-held shares of Planet Labs PBC (PL) at $25.05 ($0.93M total) on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Robinson Kristen
Published Jul 16, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 16, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PL
Neutral
high confidence
Mentioned
$PL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale of 37,107 shares at $25.0529/share, totaling $929,637.96, with holdings after the sale of 222,897 shares.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure suggests limited fundamental information content.

03

What to watch

The sale is indirect and under a pre-arranged plan; without additional context (e.g., total insider activity trend), the signal is likely weak.

Relevance 4/10Novelty 3/10Timing: Filed on 2026-07-16, transaction dated 2026-07-15.

Background

The article is a SEC Form 4 insider transaction disclosure for Planet Labs PBC, reported by director Robinson Kristen.

Company-level read

Ticker impact

$PLNeutralHigh confidence
Context

Planet Labs PBC director Robinson Kristen sold 37,107 shares in an open-market transaction worth about $929,638 under a 10b5-1 plan.

Expected impact

Likely minimal immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction, but it is explicitly tied to a pre-arranged 10b5-1 plan, reducing the likelihood of new, time-sensitive negative information.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with periods of weaker outlook or liquidity needs, so some traders may treat it as a mild negative sentiment input.

Key entities

  • Planet Labs PBC

    Company whose director insider transaction is disclosed on Form 4.

  • Robinson Kristen

    Director who executed an open-market sale under a Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SPCXMed

SPCX Stock Outperforms Space Peers This Week As RKLB, ASTS, RDW And PL Slide

SpaceX (SPCX) gained 1% this week, while peers like Redwire (RDW), Rocket Lab (RKLB), AST SpaceMobile (ASTS), and Planet Labs (PL) declined. SpaceX acquired Grain Management's spectrum for $8B, pending FCC approval, and secured a deal with American Airlines for Starlink. Up to 328.4M SPCX shares may become eligible for sale on Friday. Other companies reported mixed operational updates and market sentiment.

$PLHigh

Effective Satellite Investment Amid High Multiples for Launch Peers – SatNews

Planet Labs PBC is highlighted as a lower-multiple investment in the commercial space sector, trading at 14.6x price-to-sales, compared to 96x for SpaceX and 55x for Rocket Lab. It reported Q2 revenue of $116.1M, up 58% YoY, with a 57% gross margin and positive free cash flow. Defense revenue surged over 90% YoY, but shares are down 18.15% YTD. Analysts rate it a 'Strong Buy' with a $34.78 target, implying 99% upside.